From: The influence of etiology on surgical outcomes in neovascular glaucoma
ALL | PDR | RVO | Other | |
---|---|---|---|---|
GDD | ||||
Baerveldt (BGI) | 46 | 29 (63%) | 10 (22%) | 7 (15%) |
Ahmed (AGV) | 70 | 43 (61%) | 17 (24%) | 10 (14%) |
AGV + BGI | 4 | 2 (50%) | 1 (25%) | 1 (25%) |
GDD (BGI) + Orphan Trabeculectomy | 3 | 2 (66%) | 0 (0%) | 1 (44%) |
GDD (BGI) + CE/IOL | 4 | 3 (75%) | 1 (25%) | 0 (0%) |
GDD (AGV) + CE/IOL | 4 | 3 (75%) | 1 (25%) | 0 (0%) |
GDD + Retinal Surgery | 3 | 1 (33%) | 1 (33%) | 1 (33%) |
Tube location | ||||
Anterior Chamber | 103 | 64 (62%) | 26 (25%) | 13 (13%) |
Sulcus | 13 | 8 (62%) | 2 (15%) | 3 (23%) |
Pars plana | 4 | 2 (50%) | 0 (0%) | 2 (50%) |
Panretinal photocoagulation at surgery | 10 | 7 (70%) | 1 (10%) | 2 (20%) |
Intravitreal injection at surgery (VEGF or Steroid) | 10 | 8 (80%) | 1 (10%) | 1 (10%) |